EUVIMEDAtrasti EUVIMED
Open access

Evaluation of Fibrinolysis by Thromboelastography in Dogs With Hemorrhagic Pericardial Effusion

Margot R Ehrlich, Ian M DeStefano, Elizabeth A Rozanski, Scott Taylor, Armelle M de Laforcade, Claire R Sharp, John E Rush

Journal of Veterinary Emergency and Critical Care · 2026

DOI: 10.1111/vec.70147 ↗

At a glance

Journal article in Journal of Veterinary Emergency and Critical Care, 2026. Written by Margot R Ehrlich and 6 co-authors. Institution: Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts, USA. Major MEDLINE topics: Dog Diseases, Thrombelastography, Fibrinolysis, Pericardial Effusion. 11 references. The full text is freely available in PubMed Central. Funded by: Tufts University Cummings School of Veterinary Medicine Companion Animal Health Fund (CAHF).

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Objective

To evaluate dogs presenting with hemorrhagic pericardial effusion (PCE) for the presence of hyperfibrinolysis.

Design

Prospective observational study.

Setting

Single veterinary teaching hospital. Measurements and Main Results Dogs with PCE had blood samples collected before pericardiocentesis for PCV, total plasma protein and blood lactate concentrations, venous blood gas, and thromboelastography modified with tissue plasminogen activator (tPA‐TEG). Fibrinolysis was assessed on tPA‐TEG using the percentage of clot lysis at 30 min (LY30) after maximum clot strength (MA). Hyperfibrinolysis was defined as an LY30 of ≥20%. LY30 values were compared with values from a cohort of healthy dogs. Most dogs with PCE (14/16 [87.5%]) were hyperfibrinolytic, whereas no control dogs had hyperfibrinolysis. The median LY30 for dogs with PCE (51.5%, range: 3.0%–77.6%) was significantly higher than that of control dogs (1.3%, range: 0.0%–5.8%; p < 0.001).

Conclusions

Compared with dogs that are healthy, dogs with hemorrhagic PCE are hyperfibrinolytic as assessed by LY30 on tPA‐TEG. Given that dogs with hemorrhagic PCE may experience ongoing hemorrhage after pericardiocentesis, further investigation into the use of antifibrinolytic medications in these patients is warranted.

Subjects

MeSH terms (MEDLINE)

Dog DiseasesThrombelastographyFibrinolysisPericardial EffusionHemorrhageAnimalsDogsFemaleMaleProspective Studies

Author keywords

caninecardiac tamponadehemangiosarcomahyperfibrinolysisthromboelastographytissue plasminogen activator

Authors and institutions

  • Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts, USA.

Funding

  • Tufts University Cummings School of Veterinary Medicine Companion Animal Health Fund (CAHF)

Cite

APA

Ehrlich, M. R., DeStefano, I. M., Rozanski, E. A., Taylor, S., de Laforcade, A. M., Sharp, C. R., & Rush, J. E. (2026). Evaluation of Fibrinolysis by Thromboelastography in Dogs With Hemorrhagic Pericardial Effusion. Journal of Veterinary Emergency and Critical Care. https://doi.org/10.1111/vec.70147

Vancouver

Ehrlich MR, DeStefano IM, Rozanski EA, Taylor S, de Laforcade AM, Sharp CR, et al. Evaluation of Fibrinolysis by Thromboelastography in Dogs With Hemorrhagic Pericardial Effusion. Journal of Veterinary Emergency and Critical Care. 2026. doi:10.1111/vec.70147

BibTeX
@article{Ehrlich2026,
  author = {Ehrlich, Margot R and DeStefano, Ian M and Rozanski, Elizabeth A and Taylor, Scott and de Laforcade, Armelle M and Sharp, Claire R and Rush, John E},
  title = {Evaluation of Fibrinolysis by Thromboelastography in Dogs With Hemorrhagic Pericardial Effusion},
  journal = {Journal of Veterinary Emergency and Critical Care},
  year = {2026},
  doi = {10.1111/vec.70147}
}
Start for free →